Article
Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)
2026-06-09
Abstract excerpt
<h4>Background</h4> This study aimed to evaluate real-world adverse event (AE) signals of EV to provide evidence-based guidance for its safe clinical application. <h4>Methods</h4> Data from the FDA Adverse Event Reporting System (FAERS) database from the period of 2019 Q1–2025 Q3 were analyzed. Disproportionality analysis algorithms, including the reporting odds ratio (ROR), proportional reporting ratio (PRR), B...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c134ac28-0aae-54ce-918a-0223328f7f97
- DOI
- 10.64898/2026.06.06.26355060
